- Cylera vs Asimily: 2026 Comparison
Cylera vs Asimily:
2026 Comparison
Reviewed by Asimily Team · Last updated
Asimily publishes this comparison and is one of the two products compared. Please take this into account and perform your own assessment. Cylera details reflect Cylera’s public website, integration pages, Asimily interviews with customers and industry participants, and blog posts as of November 2026, linked where cited. Where a cell reads “not in public Cylera documentation,” we found no public source for the capability; it does not prove the capability is absent.
Summary
Cylera and Asimily both discover Internet of Medical Things (IoMT) devices, such as infusion pumps and patient monitors, without agents and generate segmentation policy for a NAC such as Cisco ISE. They differ after discovery. Cylera scores risk passively and passes device intelligence to partner tools. Asimily adds exploitability analysis, policy simulation against live traffic, IoT patching, configuration control, and pre-procurement risk data through Asimily ProSecure.
What You'll Learn
- How Cylera and Asimily compare on agentless discovery, device profiling, and integrations
- How each platform finds and prioritizes vulnerabilities, and what Asimily’s ATT&CK Analysis adds
- How each platform creates segmentation policy, and why simulating policy against live traffic matters in clinical networks
- Where Asimily adds IoT Patching, Configuration Control, recall monitoring, and pre-purchase risk modeling with Asimily ProSecure for optimal device configurations, and when Cylera is the better fit
Introduction
Both Cylera and Asimily eliminate blind spots for IoMT by identifying connected hardware without requiring endpoint software agents. They profile equipment by manufacturer, model, and operating system, calculate risk indices, and generate microsegmentation policies for Network Access Control (NAC) systems to enforce.
Where they differ is depth of execution. Cylera, founded in 2017 in New York, provides a healthcare-tailored IoT security engine combining passive monitoring, contextual risk scoring, and policy generation for third-party enforcement (Cylera, accessed November 3, 2026). Asimily expands this foundation across IoT, OT, IoMT, and IT environments. It actively validates whether vulnerabilities are exploitable in a specific network context using a vulnerability-by-vulnerability ATT&CK Analysis from Asimily Labs, and delivers proactive remediation through risk-centric prioritization, automated IoT Patching, and configuration change tracking.
Explore the detailed comparisons below, ordered by security program maturity: visibility, vulnerability management, threat response, and active risk mitigation.
1. Inventory and Visibility
Both platforms build inventory without endpoint agents. Asimily expands coverage through deep packet inspection, AI and ML classification against a library of well over 10,000,000 observed devices and profiles, active querying, flow data, and correlation with over 150 different sources, such as Active Directory, CMDB, NACs, DHCP, vulnerability scanners, EDRs, and Mobile Device Managers. Active methods suit only devices that tolerate the traffic, so Asimily pairs them with passive collection. Asimily also discovers what runs on assets, including services, applications, middleware, and AI agents, helping to create a unified, normalized inventory.
Cylera says its agentless approach “does not rely on agents, network scanning of devices, or overdue manufacturer updates.” It captures make, model, operating system, vendor, network services, and software bill of materials (SBOM) attributes.
Swipe to compare both platforms →
| Feature | Asimily | Cylera |
|---|---|---|
| Passive and Safe Active Data Collection | Yes; passive collection plus safe active querying, agentless | Yes; passive and agentless, no device scanning required |
| Deep Packet Inspection (DPI) and Network Flow Analysis | Yes; inspects headers, payloads, and network flows | No; uses proprietary Adaptive Data Type Analysis instead of DPI |
| Detailed Classification and Inventory for IoT, OT, and IoMT | Yes; inventories IoT, OT, IoMT, and IT using deep packet inspection and AI techniques | Yes; profiles make, model, OS, and SBOM attributes |
| Integrations Across the IT and Security Ecosystem | Yes; correlates and normalizes data from over 150 sources | Yes; shares device intelligence with 17 listed tools |
2. Exposure Management
Inventory feeds exposure, and both platforms score risk per device. Cylera aggregates vulnerability data from sources such as the NIST National Vulnerability Database (NVD) and IoT device manufacturer databases, scores risk from device type, vulnerability assessments, behavioral analysis, and usage, and provides “detailed, step-by-step remediation instructions customized for each identified vulnerability and risk” (Cylera, accessed November 3, 2026). Asimily ranks vulnerabilities by impact and likelihood, and its ATT&CK Analysis tests whether a vulnerability is exploitable on a specific device in its network context, so teams work from a shorter list of the riskiest devices. Asimily’s risk analysis also draws on Manufacturer Disclosure Statements for Medical Device Security (MDS2) and SBOMs, and Risk Simulator models how a fix would change a device’s risk score before anyone acts. Asimily offers three ways to reduce exposure: patching (automatically where possible), tailored remediation (alter the context or configuration to thwart exploitability), or microsegmentation (continually updated and refined).
Swipe to compare both platforms →
| Feature | Asimily | Cylera |
|---|---|---|
| Vulnerability and Threat Detection, Analysis, and Prioritization | Yes; prioritizes using vulnerability analysis in context, SBOMs, and documentation | Yes; scores risk from vulnerabilities, behavior, and usage |
| NVD and Manufacturer Vulnerability Sourcing | Yes; ingests multiple sources to find new vulnerabilities, including NVD and manufacturer databases | Yes; NVD plus IoT manufacturer databases |
| ATT&CK Analysis of Exploitability per Vulnerability in the Customer Environment | Yes; Asimily Labs analyzes each vulnerability for exploitability | No; not in public Cylera documentation |
| Targeted Mitigation Recommendations, Including on Legacy Devices | Yes; recommends mitigations per attack vector, including legacy systems | Yes; step-by-step remediation per vulnerability |
| Manufacturer Security Disclosures (MDS2) in Risk Analysis | Yes; disclosures are included in the risk analysis | No; not in public Cylera documentation |
| SBOM Incorporation in Vulnerability Analysis | Yes; included in analysis | Yes; captures SBOM attributes per device |
| Simulate Risk Changes From Remediation Scenarios | Yes; Risk Simulator models risk score changes to avoid inefficient work | No; not in public Cylera documentation |
3. Threat and Response
Both platforms detect anomalous device behavior and send threat data to security operations tools. Cylera builds “device-specific behavioral baselines” to flag anomalies (Cylera, July 3, 2025), and its Smart Threat Prioritization applies machine learning to correlate device, indicator of compromise (IOC), and in-service data. Cylera sends newly identified threats and risks to Splunk, Microsoft Sentinel, IBM QRadar, and Google Chronicle (Cylera, accessed November 3, 2026). Asimily’s anomaly policies alert or quarantine devices through NACs and supported firewalls when a policy is violated, and its SIEM integrations send anomaly events to a central system (and thus alerting). For incident response, Asimily can record packets from a monitored device, on demand or when a policy is violated, so responders start with the traffic itself and not only an alert.
Swipe to compare both platforms →
| Feature | Asimily | Cylera |
|---|---|---|
| Simple Anomaly Detection and IoC Management | Yes; seeks universal anomalies, changes, and known IoC | Yes; device behavioral baselines and IOC correlation |
| Generate Detection Rules using Simple Wizard | Yes; to create unique or preferred rules | No; not in public Cylera documentation |
| Threat Data Sent to SIEM Tools | Yes; sends anomaly events to SIEM tools | Yes; Splunk, Sentinel, QRadar, and Chronicle |
| Packet Capture From Any Device for Incident Response | Yes; optional full packet capture for any monitored asset | No; not in public Cylera documentation |
4. Risk Mitigation
Segmentation is a priority for most teams and still unfinished for many: Cisco’s 2025 Segmentation Report found that 79% call it a priority and only 33% have fully implemented it (Cisco). In clinical networks the fear of blocking a device during patient care is often what stalls enforcement. Both platforms generate access control policies to block exploits and still allow function, relying on NACs or firewalls for enforcement, such as Cisco ISE (both for DACLs and security group tags). Cylera “automatically generates recommended segmentation policies based on device profiles and clinical context” (Cylera, accessed November 3, 2026), and its Segmentation Policy Generator provides rule generation, auto-enrollment of new IoT devices, and policy monitoring. Cylera passes that intelligence to Cisco ISE over pxGrid, where TrustSec security group tags apply it (Cylera, June 20, 2025), and lists Check Point, Forescout, HPE Aruba ClearPass, and Extreme among the tools it supplies with device profiles.
Neither platform enforces at the switch itself; both rely on the NAC or firewall. Asimily can also run segmentation as a continuously updated process based on exploitability, with simulation before enforcement and an additional Enforcement Plan. Enforcement Plan is Asimily’s name for the pre-deployment checklist, that gives users a glimpse of how enforcement will work rather than hiding the details from users. Asimily’s Segmentation Orchestration creates conflict-free policies from actual device behavior, ranks them by exploitability, simulates them against live traffic with Policy Simulation, previews the Enforcement Plan, and applies policy through existing NACs and supported firewalls. Continuous Segmentation then applies NAC and firewall policies automatically to new matching devices. Asimily also adds IoT Patching and password management for supported IoT device types.
Swipe to compare both platforms →
| Feature | Asimily | Cylera |
|---|---|---|
| AI-Based Automatic Grouping and Policy Creation | Yes; groups devices and generates segmentation ACLs | Yes; Segmentation Policy Generator recommends rules |
| Targeted Segmentation Based on Attack Vectors | Yes; risk-based analysis auto-suggests safe segmentation | No; uses device profiles and clinical context instead |
| Simulate Segmentation Policy Before Enforcement | Yes; simulates policy against live traffic first | No; not in public Cylera documentation |
| Continually Adapt Policies to Changing Devices | Yes; applies safe policies as devices change (add, remove, move) | Yes; auto-enrolls new IoT devices into policy (unclear on how removals or moves are handled) |
| Harnesses Investment in Existing NACs and Firewalls | Yes; applies policy through supported NACs and firewalls | Yes; feeds profiles to NACs and Check Point |
| IoT Device Patching at Scale, With Auditability | Yes; manually or automatically patches supported IoT devices | No; provides step-by-step remediation guidance instead for some situations |
| Centralized IoT Password Management | Yes; holds IoT passwords for safe patch deployment | No; not in public Cylera documentation |
5. Governance, Risk, and Compliance
Healthcare security teams answer to auditors, clinical engineering, and finance at once. Asimily’s Configuration Control captures configuration snapshots of IoT, OT, and IoMT devices to establish a known good state, detects configuration drift, and keeps a change history for audits. Asimily ProSecure delivers strategic pre-procurement risk analysis and actionable safe configuration guidance for devices before purchase by aggregating insights across customer fleets. In addition, Asimily monitors open FDA, BfArM, and Health Canada recalls against the inventory, and utilization data, including imaging procedures for imaging devices, supports capital planning. Cylera lists “compliance audit-readiness” through “reports and data export of inventory, risks, threats, and event logs,” and collects “usage telemetry to enable optimization and cost savings” (Cylera, accessed November 3, 2026). Ask each vendor how device change records and recall actions reach auditors.
Swipe to compare both platforms →
| Feature | Asimily | Cylera |
|---|---|---|
| Device Snapshots for Configuration Control and Recovery | Yes; captures known good state for IoT, OT, IoMT | No; not in public Cylera documentation |
| Automated Detection of Configuration Changes | Yes; regularly checks for any change, authorized or unauthorized | No; not in public Cylera documentation |
| Compliance Reporting and Data Export | Yes; reports on any platform attribute | Yes; reports and exports for audit readiness |
| Pre-Procurement Risk Modeling (IoMT) | Yes; full data on IoMT devices and safe configurations | No; not in public Cylera documentation |
| Out-of-the-Box Device Hardening Recommendations (IoMT) | Yes; safe configurations based on prior deployments | No; not in public Cylera documentation |
| Medical Device Recall Monitoring | Yes; monitors FDA, BfArM, and Health Canada recalls | No; not in public Cylera documentation |
| Device Utilization Data | Yes; per-device utilization, including imaging procedures | Yes; usage telemetry for optimization and cost savings |
6. Sample Integrations
Both platforms integrate across IT, security, and clinical engineering tools. Cylera lists 17 integrations, including Cisco ISE, HPE Aruba ClearPass, Forescout, Extreme, Check Point, ServiceNow, Nuvolo, eQuip, Rapid7 InsightVM, Illumio, and four SIEM tools; most send Cylera’s device intelligence to the partner, and a few import device location or vulnerability data (Cylera, accessed November 3, 2026). Asimily correlates network, identity, endpoint, clinical engineering, and service management data, plus scanner results, into one record per device, and can apply policy through supported NACs and firewalls. Asimily integration categories and sample products include:
- AI & LLM Providers: Google Gemini, Anthropic Claude, others
- CMMS / CMDB: ServiceNow Service Graph, Nuvolo, i-doit, EQ2
- DHCP & DNS: Infoblox, BlueCat, EfficientIP
- Endpoint Detection and Response (EDR): CrowdStrike Falcon, Microsoft Defender, SentinelOne
- Firewalls & Network Infrastructure: FortiGate, Arista Agni, Juniper
- Identity and Access Management (IAM): Active Directory/LDAP, Azure SSO, SAML, Okta
- ITSM: ServiceNow ITSM, Jira, BMC Helix
- Location Services: Cisco Spaces, Aruba AirWave
- Mobile Device Management: Microsoft Intune, Jamf Pro, Jamf Cloud
- Network Access Control (NAC): Cisco ISE, Aruba ClearPass, FortiNAC, Forescout, Palo Alto Panorama
- Network Traffic Sources: NetFlow, sFlow, SNMP Walk
- Scanners and Vulnerability Management (VM): Tenable, Qualys, Rapid7
- SIEM: Elastic SIEM, CrowdStrike LogScale, Palo Alto Cortex XSOAR
- Threat Intelligence: Cisco XDR, CrowdStrike Falcon X
This is not a complete list. Integrations are added regularly and there are over 150 at this time.
7. Deployment Considerations
Both platforms avoid endpoint agents. Cylera’s datasheet describes “passive and agentless deployment” (Cylera, accessed November 3, 2026), and its Network Traffic Emulation creates virtual stand-ins for real IoT devices during active scans and probing. A customer-written Cisco Community guide describes a Cylera appliance at each site that collects traffic from a switch SPAN port and forwards it to Cylera’s cloud application (Cisco Community); Cylera’s own pages do not state its deployment options. Asimily is delivered as a cloud-based software as a service (SaaS) with on-premises deployment available, and collects data through Asimily Edge software on a dedicated appliance, a virtual machine, or switches that support Cisco application hosting.
Swipe to compare both platforms →
| Deployment Factor | Asimily | Cylera |
|---|---|---|
| Agents Required | None | None |
| Environment | Cloud, on-premises | Not stated in public Cylera documentation |
| Data Collection | Sub-1U, 1U, Virtual Collectors | On-site appliance on SPAN or tap |
Worked Example: Segmenting a Group of Infusion Pumps
This example is illustrative, not a customer story. Observe: Asimily’s passive analysis shows infusion pumps on one VLAN talking to a drug library server and a time server, and to nothing else. Profile: Asimily classifies the pumps by make, model, and firmware, pulls the manufacturer’s MDS2 data, and ATT&CK Analysis shows which of their exposures an attacker could actually use, so the group ranks high. Propose: Segmentation Orchestration drafts a policy that allows only the observed flows. Simulate: Policy Simulation runs the draft against live traffic over a period the team chooses and lists any port or service that would be blocked, before anything changes on a clinical network. Enforce: the Enforcement Plan shows the steps for the team’s existing NAC, such as a downloadable ACL (DACL) on Cisco ISE or Aruba ClearPass, or for a supported firewall.
How to Test Both in a Proof of Value
Asimily’s stated expectation is value within 48 hours and most devices identified within 14 days. Run the same six checks on Cylera and on Asimily, on one site of your own network:
- List the devices each platform finds on a sample clinical VLAN, including IoT, OT, and IT devices beyond medical equipment.
- Ask which discovered vulnerabilities are exploitable in your environment, and why.
- Take one proposed segmentation policy and record what it would block against observed traffic before it is enforced.
- Confirm which enforcement point applies the policy, and how a change is rolled back.
- Check what each platform does for a device that can be patched and for one that cannot.
- Ask about recall tracking, configuration change history, data export, deployment model, and renewal terms.
When Cylera Fits Better
Cylera is a close fit for a hospital-only security program that wants a specialist vendor and already runs the network tools Cylera feeds. These cases favor Cylera:
- Healthcare-only focus. Cylera describes itself as trusted by healthcare networks and hospitals globally, and builds segmentation recommendations on “clinical context” (Cylera, accessed November 3, 2026).
- No probing of live devices. Cylera’s Network Traffic Emulation creates virtual stand-ins for IoT devices during active scans and probing (Cylera, accessed November 3, 2026), which suits teams that will not allow any query to reach a medical device.
- Existing Cisco ISE and TrustSec programs. Cisco’s Security Technical Alliance Partners pages list Cylera, which “integrates with Cisco ISE over pxGrid to bring medical IoT visibility into ISE” (Cisco, accessed November 3, 2026).
- Broad SIEM coverage. Cylera lists integrations with Splunk, Microsoft Sentinel, IBM QRadar, and Google Chronicle.
- UK and NHS presence. Cylera operates regional offices in the US and the UK (Cylera) and has announced contracts with NHS trusts.
The Bottom Line
Cylera: Cylera is a healthcare-focused IoT security platform that discovers and profiles devices passively and without agents, scores risk, detects anomalies, and generates segmentation policy that partner NACs such as Cisco ISE enforce. It suits hospital teams that want a specialist vendor and already run Cisco ISE or one of its other listed integrations.
Asimily: Asimily covers any connected asset: it builds the inventory first across IoT, OT, IoMT, and IT assets and the software running on them, then analyzes exploitability with a MITRE-based ATT&CK Analysis, then creates, simulates, and continuously maintains segmentation policy that existing NACs and supported firewalls enforce. Apart from discovery and segmentation, Asimily adds IoT Patching, Configuration Control, packet capture, recall monitoring, and Asimily ProSecure pre-procurement risk data with fleet-wide safest configuration recommendations. Like Cylera, it does not enforce at the switch, so it works through the NAC or firewall a team already runs.
Swipe to compare both platforms →
| Choose Cylera When | Choose Asimily When |
|---|---|
| Your security program covers hospitals and clinics only, and you want a healthcare specialist | You need one platform for IoT, OT, IoMT, and IT devices across hospitals, labs, offices, and facilities |
| You will not allow any query to reach a medical device and want emulated stand-ins for scans | You judge platforms on inventory results rather than collection method, and want ATT&CK Analysis of exploitability to decide which devices get policy first |
| You run Cisco ISE with TrustSec and want device profiles fed to it over pxGrid | You want to simulate policy against live clinical traffic and review an Enforcement Plan before any change |
| Your SOC runs Splunk, QRadar, or Google Chronicle and wants device threats there | You want IoT Patching, Configuration Control, packet capture, recall monitoring, and pre-purchase risk data in the same platform |
Request a demo
See how Asimily turns exploitable risk into segmentation policy you can simulate before it deploys, alongside the NAC you already run.
Related Resources
Best IoMT and Healthcare Cybersecurity Platforms 2026
Read more best iomt healthcare cybersecurity platformsClaroty vs Asimily: 2026 Comparison
Read more Claroty (Medigate) vs Asimily: 2026 ComparisonArmis vs Asimily: 2026 Comparison
Read more Armis vs Asimily: 2026 ComparisonORDR vs Asimily: 2026 Comparison
Read more ORDR vs Asimily: 2026 ComparisonForescout vs Asimily: 2026 Comparison
Read more Forescout vs Asimily: 2026 ComparisonNetwork Segmentation FAQ
Read more Network Segmentation FAQ: Building, Deploying, and Maintaining Segmentation PolicyFrequently Asked Questions
Frequently Asked Questions
The main difference is how far each platform carries a finding after discovery. Both discover connected medical and IoT devices without agents and generate segmentation policy for NACs to enforce. Asimily monitors IoMT, but also the ancillary IoT, OT, and IT that they depend on and that are typically protected by the same team. It adds ATT&CK Analysis of exploitability for each vulnerability, simulates segmentation policy against live traffic before enforcement, and adds IoT Patching, Configuration Control, and recall monitoring. Cylera focuses on healthcare nearly exclusively and feeds device profiles to partner NACs, firewalls, and SIEM tools.
Yes. Agentless discovery is standard for IoT, IoMT, and OT security, since most of those devices can’t host agents. Cylera describes its deployment as “passive and agentless” and says its approach “does not rely on agents, network scanning of devices, or overdue manufacturer updates” (Cylera, accessed November 3, 2026). Asimily is also agentless. It combines passive network traffic analysis with safe active querying, using vendor-approved methods only on devices that tolerate them, plus data from integrations, collected through Asimily Edge software or an appliance.
Cylera says its Adaptive Data Type Analysis extracts device context from traffic over known and unknown protocols “while avoiding the limitations of DPI-based systems that rely on protocol decoder libraries” (Cylera, accessed November 3, 2026). Asimily’s view is that protocol decoders make classification precise, rapid, and accurate. Asimily uses deep packet inspection of headers and payloads, plus network flow analysis, AI and ML classification, active querying where safe, and correlation with integration data. Buyers should compare classification depth on their own devices.
We found no public Cylera documentation that describes simulating segmentation policy against live traffic before enforcement. Cylera’s Segmentation Policy Generator lists rule generation, auto-enrollment of new IoT devices, and policy monitoring. Asimily’s Policy Simulation tests a proposed policy against live traffic over a period the team chooses and shows which ports and services it would block, and its Enforcement Plan lets administrators review each step before deployment. Ask Cylera to demonstrate its pre-enforcement testing.
Yes. Cylera connects to Cisco ISE over pxGrid and supplies custom healthcare IoT endpoint profiles that ISE uses to create policies, with TrustSec security group tags applying microsegmentation (Cylera, June 20, 2025). Asimily also integrates with Cisco ISE over pxGrid and pushes generated policy, such as downloadable ACLs (DACLs) and security group ACLs (SGACLs), to ISE after Policy Simulation. Both rely on ISE or another NAC/firewall to enforce.
We found no public Cylera documentation of device patching. Cylera provides “detailed, step-by-step remediation instructions customized for each identified vulnerability and risk” (Cylera, accessed November 3, 2026). Asimily’s IoT Patching manually or automatically patches supported IoT device types, with centralized password management, and recommends targeted mitigations or segmentation for devices that cannot be patched, including legacy medical devices.
Cylera is primarily a healthcare platform. Its homepage says it is “trusted by healthcare networks and hospitals globally,” and its solutions menu also lists financial services, higher education, transportation and logistics, and manufacturing (Cylera, accessed November 3, 2026). Asimily covers IoT, OT, IoMT, and IT assets for healthcare, manufacturing, utilities, government, critical infrastructure, and enterprise organizations.
Cylera is a privately held company founded in 2017 and headquartered in New York, led by co-founder and CEO Timur Ozekcin (Cylera, accessed November 3, 2026). In March 2021 it announced $17 million in total funding, led by Concord Health Partners and Maverick Ventures (BusinessWire, March 18, 2021). As of November 2026, we found no public record of an acquisition or a later funding round.
Usually not both. The two platforms overlap on discovery, risk scoring, and NAC policy, so teams typically replace one with the other rather than run them side by side. Teams consider switching when they need exploitability analysis, policy simulation before enforcement, IoT patching, configuration control, or coverage beyond medical devices. A proof of value at one site shows whether the difference matters in your environment.
Asimily ProSecure is a module that provides pre-procurement risk analysis and device security modeling before equipment is purchased. By evaluating risk data and standard deployment patterns across customer fleets, ProSecure enables healthcare security and procurement teams to evaluate vendor security profiles, forecast potential vulnerabilities, and adopt the safest device configurations out-of-the-box.
Common alternatives to Cylera for healthcare device security include Armis, Asimily, Axonius (which acquired Cynerio in 2025), Claroty (which acquired Medigate), Forescout, and Ordr. Claroty and Armis cover healthcare alongside industrial or enterprise environments, Forescout adds network access control, and Ordr focuses on connected asset visibility and segmentation. Asimily differs by carrying a finding through to a fix: ATT&CK Analysis, then simulated segmentation policy, IoT Patching, and Configuration Control.
Sources
- Cylera platform page, accessed November 3, 2026: Adaptive Data Type Analysis, Network Traffic Emulation, Segmentation Policy Generator, Smart Threat Prioritization, SBOM attributes, usage telemetry, compliance reports
- Cylera integrations page, accessed November 3, 2026: 17 named integrations
- Cylera network segmentation and protection page, accessed November 3, 2026
- Cylera vulnerability and risk management page, accessed November 3, 2026
- Cylera blog, June 20, 2025: Cisco ISE, pxGrid, TrustSec, Catalyst Center
- Cylera blog, July 3, 2025: real-time monitoring and behavioral baselines
- Cylera Platform datasheet, accessed November 3, 2026
- Cylera company page, accessed November 3, 2026
- BusinessWire, March 18, 2021: Cylera announces $17 million in total funding
- Cisco technical alliance partner page: Cylera
- Cisco Community guide: Cylera and Cisco ISE deployment
- Cisco 2025 Segmentation Report
- SiliconANGLE, July 2025: Axonius acquires Cynerio
Gartner does not endorse any vendor, product, or service depicted in its research publications.